Our Featured Research Page lists cancer prevention, treatment and quality of life studies enrolling people with or at high risk for hereditary cancers. You can do a quick search to filter our featured studies by cancer type, study type or key word, or a more in-depth search through clinicaltrials.gov.
Search Results: Prevention, Detection & Risk + Breast Cancer + Risk Reduction (4 results)

Prevention
Latinas with a high risk of breast cancer
Helping Latinas Understand Their Risk for Breast Cancer and Get Breast Cancer Care
This study will teach Latinas with a high risk of breast cancer about how diet, exercise, ethnicity, genetics and screening and prevention guidelines may impact their likelihood for developing breast cancer.

Prevention
Prevention study enrolling women ages 25-55 with a BRCA1 mutation
Denosumab for breast cancer risk reduction in women with an inherited BRCA1 mutation (The Breast Cancer Prevention Study)
This is a study to test the effectiveness of a drug (denosumab) on preventing the development of breast cancer in women with an inherited BRCA1 mutation.
Denosumab is a drug that is currently used to treat bone loss in order to reduce the risk of broken bones in healthy people, and is also used to reduce new bone growths in cancer patients whose cancer has spread to their bones. Research has shown that denosumab may also reduce the risk of developing breast cancer in women with an inherited BRCA1 mutation.

Prevention
Study for people undergoing DIEP flap reconstruction
Restoring Sensation after DIEP Flap Reconstruction
The goal of this study is to look at how well a nerve graft works for improving sensation to the reconstructed breast after mastectomy in people undergoing DIEP flap reconstruction (deep inferior epigastric perforator flap).

Prevention
People with a BRCA1 or BRCA2 mutation
Testing a Vaccine for Cancer Prevention in People with a BRCA1 or BRCA2 Mutation
This study will look at a new vaccine known as INO-5401 used alone or combined with a second vaccine called INO-9012. The study will test if the vaccine is safe (without large side effects) and test a new way of giving vaccines. It will also test whether the vaccine activates the immune system. A goal of this research is to reduce cancer risk in people with a BRCA1 or BRCA2 mutation. Additional studies will be needed to learn if this vaccine approach lowers cancer risk in mutation carriers.
Additional Results on Clinicaltrials.gov Prevention, Detection & Risk + Breast Cancer + Risk Reduction
9 results
Research Search Tool Sponsored By:

